CA2564379A1 — Aerosol formulation for inhalation of beta agonists
Assigned to Boehringer Ingelheim International GmbH · Expires 2005-11-24 · 20y expired
What this patent protects
The invention relates to a propellant-free aerosol formulation for inhalation, which comprises one or more compounds of general formula (1), wherein the groups R1, R2, R3 and X- are defined as in the claims and in the description.
USPTO Abstract
The invention relates to a propellant-free aerosol formulation for inhalation, which comprises one or more compounds of general formula (1), wherein the groups R1, R2, R3 and X- are defined as in the claims and in the description.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.